title: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
abstract: Ceramide produced by sphingomyelinases (SMases) has been recognized as an important second messenger in growth factor receptor signaling. Tumor necrosis factor (TNF), through binding to the 55 kDa TNF receptor (TNF-R55), rapidly activates two distinct types of SMase, a membrane-associated neutral (N-)SMase, and an endosomal acidic (A)-SMase. N-SMase and A-SMase are activated independently by different cytoplasmic domains of TNF-R55. Each type of SMase specifically couples to select pathways of TNF signaling. Ceramide generated by N-SMase directs the activation of proline-directed serine/threonine protein kinase(s) and phospholipase A2. In contrast, A-SMase triggers the activation of NF-kappa B. No apparent crosstalk was detected between N-SMase and A-SMase pathways, indicating that ceramide action depends on the topology of its production. These results suggest that N-SMase and A-SMase control important yet dissociable and nonoverlapping pathways of TNF receptor signal transduction.
authors.affiliation: Institut für Medizinische Mikrobiologie und Hygiene, Technische Universität München, Federal Republic of Germany.
authors.forename: K
authors.initials: K
authors.lastname: Wiegmann
authors.forename: S
authors.initials: S
authors.lastname: Schütze
authors.forename: T
authors.initials: T
authors.lastname: Machleidt
authors.forename: D
authors.initials: D
authors.lastname: Witte
authors.forename: M
authors.initials: M
authors.lastname: Krönke
mesh_terms: D000818:Animals; D001483:Base Sequence; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D002518:Ceramides / Q000378:metabolism; D004789:Enzyme Activation; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007527:Isoenzymes / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000032:analysis; D009636:Norbornanes; D010741:Phospholipases A / Q000032:analysis; D054467:Phospholipases A2; D011494:Protein Kinases / Q000032:analysis; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D015290:Second Messenger Systems / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D013108:Sphingomyelin Phosphodiesterase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013859:Thiocarbamates; D013871:Thiones / Q000494:pharmacology; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D010738:Type C Phospholipases / Q000032:analysis
chemical_list: D001952:Bridged-Ring Compounds; D002518:Ceramides; D007527:Isoenzymes; D016328:NF-kappa B; D009636:Norbornanes; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D013859:Thiocarbamates; D013871:Thiones; D014409:Tumor Necrosis Factor-alpha; C046498:tricyclodecane-9-yl-xanthogenate; D011494:Protein Kinases; D010741:Phospholipases A; D054467:Phospholipases A2; D010738:Type C Phospholipases; D013108:Sphingomyelin Phosphodiesterase